PMID- 30799306 OWN - NLM STAT- MEDLINE DCOM- 20191016 LR - 20211204 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 294 IP - 14 DP - 2019 Apr 5 TI - Aminoacyl-tRNA synthetases and tRNAs in human disease: an introduction to the JBC Reviews thematic series. PG - 5292-5293 LID - 10.1074/jbc.REV119.007721 [doi] AB - Aminoacyl-tRNA synthetases (ARSs) catalyze the attachment of specific amino acids to cognate tRNAs for use in protein synthesis. This historical function of ARSs and tRNAs is fairly well understood. However, ARSs and tRNAs also perform noncanonical functions that are continuing to be unveiled at a rapid pace. The expanded functions of these essential molecules of life range from roles in retroviral replication to stimulation of mammalian target of rapamycin (mTOR) activity; DNA repair, splicing, and transcriptional and translational regulation; and other aspects of cellular homeostasis. Furthermore, mutations in tRNAs and synthetases are known to drive human maladies, such as the neurodegenerative disorder Charcot-Marie-Tooth disease along with other central nervous system dysfunctions and cancer. This series of reviews focuses on the diseases that result from natural variations in human cytoplasmic tRNAs, as well as from mutations in mitochondrial tRNAs and ARSs. Ultimately, the exciting work in this rapidly emerging area may lead to new therapies for microbial and parasitic infections, cancer, and neurodegenerative diseases. CI - (c) 2019 Musier-Forsyth. FAU - Musier-Forsyth, Karin AU - Musier-Forsyth K AUID- ORCID: 0000-0002-0354-4172 AD - From the Department of Chemistry and Biochemistry, Center for RNA Biology, and Center for Retroviral Research, The Ohio State University, Columbus, Ohio 43210 musier-forsyth.1@osu.edu. LA - eng PT - Introductory Journal Article DEP - 20190224 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Neoplasm Proteins) RN - 0 (RNA, Neoplasm) RN - 9014-25-9 (RNA, Transfer) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 6.1.1.- (Amino Acyl-tRNA Synthetases) SB - IM MH - Amino Acyl-tRNA Synthetases/genetics/*metabolism MH - Charcot-Marie-Tooth Disease/genetics/*metabolism/pathology MH - DNA Repair MH - Humans MH - *Mutation MH - Neoplasm Proteins/genetics/*metabolism MH - Neoplasms/genetics/*metabolism/pathology MH - RNA, Neoplasm/genetics/metabolism MH - RNA, Transfer/genetics/metabolism MH - Retroviridae/physiology MH - Retroviridae Infections/genetics/*metabolism MH - TOR Serine-Threonine Kinases/genetics/metabolism MH - Virus Replication PMC - PMC6462500 OTO - NOTNLM OT - Charcot-Marie-Tooth disease (CMT) OT - aminoacyl tRNA synthetase OT - cancer OT - human disease OT - human immunodeficiency virus (HIV) OT - mitochondrial tRNA-synthetases OT - multisynthetase complex OT - neurological disease OT - therapeutic targets OT - transfer RNA (tRNA) COIS- The author declares that she has no conflicts of interest with the contents of this article. EDAT- 2019/02/26 06:00 MHDA- 2019/10/17 06:00 PMCR- 2019/02/24 CRDT- 2019/02/26 06:00 PHST- 2019/02/26 06:00 [pubmed] PHST- 2019/10/17 06:00 [medline] PHST- 2019/02/26 06:00 [entrez] PHST- 2019/02/24 00:00 [pmc-release] AID - S0021-9258(20)35492-2 [pii] AID - REV119.007721 [pii] AID - 10.1074/jbc.REV119.007721 [doi] PST - ppublish SO - J Biol Chem. 2019 Apr 5;294(14):5292-5293. doi: 10.1074/jbc.REV119.007721. Epub 2019 Feb 24.